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of repolarization between well-coupled ventricular and
Purkinje fibersFn1 1
Tamás Árpádffy-Lovas, Zoltán Husti, István Baczkó, András Varró, and László Virág
Abstract: Increased transmural dispersion of repolarization is an established contributing factor to ventricular tachyar-
rhythmias. In this study, we evaluated the effect of chronic amiodarone treatment and acute administration of dofetilide in
canine cardiac preparations containing electrotonically coupled Purkinje fibers (PFs) and ventricular muscle (VM) and com-
pared the effects to those in uncoupled PF and VM preparations using the conventional microelectrode technique. Disper-
sion between PFs and VM was inferred from the difference in the respective action potential durations (APDs). In coupled
preparations, amiodarone decreased the difference in APDs between PFs and VM, thus decreasing dispersion. In the same
preparations, dofetilide increased the dispersion by causing a more pronounced prolongation in PFs. This prolongation was
even more emphasized in uncoupled PF preparations, while the effect in VM was the same. In uncoupled preparations, ami-
odarone elicited no change on the difference in APDs. In conclusion, amiodarone decreased the dispersion between PFs and
VM, while dofetilide increased it. The measured difference in APD between cardiac regions may be the affected by electro-
tonic coupling; thus, studying PFs and VM separately may lead to an over- or underestimation of dispersion.
Key words: dispersion of repolarization, chronic amiodarone, dofetilide, electrotonic coupling, cardiac Purkinje fibers.
Résumé : Il est établi que l’augmentation de la dispersion de la repolarisation à travers la paroi constitue un facteur contri-
butif aux tachyarythmies ventriculaires. Dans cette étude, nous avons évalué l’effet de l’administration d’amiodarone à
long terme et de l’administration aiguë de dofétilide dans des préparations canines de cœur contenant des fibres de Pukinje
(FP) et du muscle ventriculaire (MV) couplés électrotoniquement, ainsi que comparé les effets à ceux de préparations de FP
et de MV découplés, et ce, à l’aide de la technique de microélectrode classique. La dispersion entre les FP et le MV était
déduite de la différence entre les durées des potentiels d’action (DPA) respectives. Dans les préparations couplées, l’amio-
darone entraînait une diminution de la différence entre la DPA des FP et du MV, et donc une diminution de la dispersion.
Dans les mêmes préparations, le dofétilide entraînait une augmentation de la dispersion par une prolongation plus mar-
quée dans les FP. Cette prolongation était encore plus prononcée dans les préparations de FP découplées, tandis que l’effet
était le même dans le MV. Dans les préparations découplées, l’amiodarone n’entraînait pas de changement dans la différ-
ence entre les DPA. En conclusion, l’amiodarone entraînait une diminution de la dispersion entre les FP et le MV, tandis
que le dofétilide entraînait une augmentation de celle-ci. La différence mesurée entre la DPA des régions cardiaques pour-
rait être affectée par le couplage électrotonique; l’étude des FP et du MV séparément pourrait donc mener à une sous- ou
une surestimation de la dispersion. [Traduit par la Rédaction]
Mots-clés : dispersion de la repolarisation, amiodarone à long terme, dofétilide, couplage électrotonique, fibres de Purkinje
cardiaques.
Introduction
Dispersion of repolarization affects variousmechanisms in car-
diac arrhythmogenesis. Increased transmural dispersion is an
established contributing factor to ventricular tachyarrhythmias
(VTs), such as Torsades de Pointes arrhythmias (Antzelevitch
et al. 1998). Transmural dispersion has been reduced by amioda-
rone ex vivo in canine wedge preparations (Sicouri et al. 1997) as
well as human transmural slice preparations (Drouin et al. 1998).
In vivo, transmural dispersion is derived from QT/QTc or JTc dis-
persion in the ECG, which have all been decreased by chronic
amiodarone in a clinical setting (Cui et al. 1994, 1998), whilst dofe-
tilide has increased global electrical heterogeneity (Stabenau
et al. 2020).
Another region characterized by high dispersion is the junc-
tion between Purkinje fibers (PFs) and the ventricular myocar-
dium (VM), also known as the Purkinje–muscle junction (PMJ).
The PMJ has been described as a contributor to local heterogeneity
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of ventricular action potential duration (APD) (Walton et al. 2014;
Martinez et al. 2018). Based on this, if PF repolarization lengthening
is markedly stronger than that of the surrounding VM at the PMJ,
early afterdepolarization (EAD) may develop in PFs, which under
certain conditions can evoke propagating extra beats in VM (Nattel
and Quantz 1988; Varró et al. 1990). As such, PF repolarization
lengthening can serve as a trigger for arrhythmias; in addition,
increased dispersion of repolarization itself can also enhance the
risk of tachyarrhythmia in the PMJ as a substrate for arrhythmia
(Nogami 2011a, 2011b)AQ1 . While transmural dispersionmay be directly
measured ex vivo and closely estimated in vivo, studying the dis-
persion of repolarization between PFs andVM is currently only pos-
sible in preparations containing electrotonically well coupled PFs
and VM. Studying the effects of antiarrhytmic agents or agent can-
didates in such preparations may be beneficial, since decreasing
dispersion could be a valid goal. Screening for drug candidates that
do not increase dispersion may also increase cardiac safety. Even
though the general electrophysiological effects of dofetilide (selec-
tive IKr inhibitor) and amiodarone (complex mechanism) are well
understood, their effect on the dispersion between PsF and VM
may only be estimated based on measurements from individual,
uncoupled preparations. The aim of this study was to assess the
effects of these two widely used antiarrhythmic drugs with estab-
lished class III actions in preparations containing well-coupled PFs
and VM to uncover additional features of these agents in the con-
text of local dispersion.
Materials andmethods
Animals
All experiments were carried out in compliance with the Guide
for the Care and Use of Laboratory Animals (USA NIH publication
No. 85-23, revised 1996) and conformed to the Directive 2010/63/
EU of the European Parliament. The protocols have been
approved by the Ethical Committee for the Protection of Animals
in Research of the University of Szeged, Szeged, Hungary (ap-
proval No. I-74-24-2017) and by the Department of Animal Health
and Food Control of the Ministry of Agriculture and Rural Devel-
opment (authority approval No. XIII/3331/2017).
Conventional microelectrode technique
Action potentials were recorded in preparations containing
both electrotonically coupled subendocardial VM and PFs and in
preparations in which VM and PF had been cut out separately
(uncoupled preparations) obtained from the left ventricle and
right ventricle of dogs using conventional microelectrode tech-
nique. Beagle dogs, either untreated or orally treated with amio-
darone (50 mg · kg–1 · day–1,AQ2 4 weeks), of either sex weighing 10–15
kg were sacrificed (sodium pentobarbital, 30 mg/kg administered
intravenously) after an intravenous injection of 400 U/kg hepa-
rin. Then the heart of each animal was rapidly removed through
a right lateral thoracotomy. The heart was immediately rinsed in
oxygenated modified Locke’s solution containing (in millimoles
per litre): NaCl 128.3, KCl 4, CaCl2 1.8, MgCl2 0.42, NaHCO3 21.4,
and glucose 10. The pH of this solution was set between 7.35 and
7.4 when gassed with themixture of 95% O2 and 5% CO2 at 37 °C.
Preparations, containing free-running PFs and VM 25–35 mm
in diameter and 2–4 mm in thickness (electrotonically coupled
preparations from the left ventricle) (F1 Figs. 1A–1C) and individual
PFs (Fig. 1E) with small muscle endings and individual papillary
VM (Figs. 1D, electrotonically uncoupled preparations from both
of the left and right ventricle) were obtained and individually
mounted in a tissue chamber with a volume of 50 mL. Electro-
tonically coupled preparations were paced from a PF, mimicking
physiological cardiac conduction. Stimulation was executed
using a pair of platinum electrodes in contact with the prepara-
tion using rectangular current pulses of 0.5–2 ms duration. These
stimuli were delivered at a constant cycle length of 1000ms for at
least 60 min allowing the preparation to equilibrate before the
measurements were initiated. Transmembrane potentials were
simultaneously recorded from PF and subendocardial VM using
conventional glass microelectrodes (Fig. 1) filled with 3 mol/L KCl
and having tip resistances of 5–20 MX connected to the input of a
high-impedance electrometer (Experimetria, type 309, Budapest,
Hungary), which was coupled to a dual-beam oscilloscope. The
resting potential (RP), action potential amplitude (APA), maxi-
mum upstroke velocity (Vmax), and APDmeasured at 50% and 90%
of repolarization (APD50 and APD90, respectively) were online
monitored and offline recorded using a home-made software
(APES) running on a computer equipped with an ADA 3300 ana-
log-to-digital data acquisition board (Real Time Devices, Inc.,
State College, Pennsylvania) having a maximum sampling fre-
quency of 40 kHz. Dispersion of repolarization was inferred from
the difference of APD90 values of PFs and VM, referred to as
DAPD90. Stimulation with a constant cycle length of 1000 ms was
applied in the course of all experiments. Attempts were made to
maintain the same impalement throughout each experiment. In
case an impalement became dislodged, adjustment was attempted,
and if the action potential characteristics of the reestablished
impalement deviated by less than 5% from the previous measure-
ment, the experiment continued (Lengyel et al. 2001; Jost et al.
2005; Orvos et al. 2015 AQ3, 2019). All measurements were carried out at
37 °C.
Statistical analysis
All data are expressed as means 6 SEM. The “n” number refers
to the number of experiments. Depending on the type of compar-
ison, Student’s t test was used either for independent samples
(amiodarone) or for paired samples (dofetilide). The results were
considered statistically significant when pwas<0.05.
Results
Comparison of baseline electrophysiology of electrotonically
coupled and uncoupled preparations
In electrotonically coupled control preparations ( T1,T2Tables 1 and 2;
F2-F3Figs. 2A and 3A) most action potential characteristics both of PF
and VM were comparable to those of individual PF and VM
(uncoupled) preparations (n = 21) ( T3,T4Tables 3 and 4; Figs. 2C and 3C).
VM APD was slightly longer in coupled preparations compared to
the uncoupled preparations (Tables 3 and 4; Figs. 2C and 3C), while
PF APD was slightly shorter in coupled preparations. APA, Vmax,
and RP were similar to those of uncoupled (individual) prepara-
tions. Baseline dispersion (DAPD90) was 39.6 6 4.0 ms (pooled con-
trols, n = 21) in coupled control groups of the drug studies.
Conduction time (CT) to PFs was shorter in all preparations than
that of VM, confirming an anterograde wave of depolarization.
Since individual, electrotonically uncoupled PF and VM prepara-
tions were not necessarily taken from the same heart and were not
in connection, differences in their APD cannot be directly meas-
ured, but average values showed an APD difference of 72.8 ms
between the two groups of preparations under control circumstan-
ces (pooled controls, n = 13 and 16).
Effects of amiodarone
Electrotonically coupled preparations obtained from animals
after chronic amiodarone treatment (n = 11) did not show statisti-
cally significant changes in the RP, APA, and Vmax. Amiodarone
treatment increased APD90 and APD75 values of PF potentials (p<
0.01) (Table 1; Fig. 2B) while eliciting no effect on the early phases
of repolarization. In VM, prolongation was measured in all stages
of repolarization, from APD10 to APD90 (p < 0.01). The prolonga-
tion of AP duration in VM was more pronounced than in PFs;
thus, DAPD90 decreased substantially (18.0 6 5.0 ms vs. 45.7 6 5.7
ms, p< 0.01). APA and Vmax of VM remained unchanged compared
to the control.
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In uncoupled PF preparations, APD90 and APD75 were increased
(p < 0.05); the prolongation was more pronounced than in
coupled preparations (Table 3; Fig. 2D). In uncoupled VM prepara-
tions, APD90 and APD50 were also increased (p < 0.01), although
this change was less pronounced compared to the VM measure-
ments from coupled preparations. These effects reflected an im-
portant difference between coupled and uncoupled preparations
in response to chronic amiodarone treatment. Accordingly, in
uncoupled preparations, amiodarone increased APD without sig-
nificantly changing dispersion of repolarization between PF and
VM,measured as DAPD90. On the contrary, in coupled preparations,
amiodarone increased APD in such a manner to result in a signifi-
cant decrease of dispersion of repolarization,measured asDAPD90.
Effects of dofetilide
In coupled preparations, acutely administered dofetilide (n = 8,
50 nM) induced a marked increase in APD90, APD75 and APD50
(p < 0.001) values in PF compared to control measurements (Table 2,
Fig. 3B). In VM, APD90 and APD75 values were also prolonged
(p < 0.01 and p < 0.05 respectively), and APD50 was markedly
increased. Themore pronounced prolongation of AP duration in PFs
led to an increase in DAPD90 to 75.2 6 12.6 ms from 47.0 6 11.1 ms
Table 1. The electrophysiological effects of 50 mg·kg–1·day–1 amiodarone in electrotonically coupled (“C”) Purkinje fiber (PF) and ventriculat
muscle (VM) preparations at a basic cycle length of 1000 ms.
Sample CT (ms) RP (mV) APA (mV) Vmax (V/s) APD90 (ms) APD50 (ms) APD90 difference (ms)
Control PF-C (14) 5.260.7 –88.463.2 119.262.6 515.6643.2 259.865.5 170.965.7 41.065.6
Amiodarone (50 mg·kg–1·day–1) PF-C (11) 4.060.6 –84.662 120.762.8 516.2667.2 305.965.8### 184.8610.9 18.065##
Control VM-C (14) 13.561.2 –85.861.6 110.162.9 201.3627.9 218.867.6 165.065.5
Amiodarone (50 mg·kg–1·day–1) VM-C (11) 12.761.6 –87.862.7 106.863.8 150.4646.1 288.065.9### 218.267.6###
Note: CT, conduction time; RP, resting potential; APA, action potential amplitude; Vmax, maximum rate of depolarization; APD90 and APD50, action potential
durations at 90% and 50% of repolarization. Results are means6 SEM. ##p< 0.01, ###p< 0.001, Student’s t test for unpaired data.
Table 2. The electrophysiological effects of 50 nmol/L dofetilide in electrotonically coupled (“C”) Purkinje fiber (PF) and ventriculat muscle (VM)
preparations at a basic cycle length of 1000 ms.
Sample CT (ms) RP (mV) APA (mV) Vmax (V/s) APD90 (ms) APD50 (ms) APD90 difference (ms)
Control PF-C (7) 6.560.9 –90.563.8 123.164.7 369.2655 265.064.4 203.464.4 37.064.3
Dofetilide (50 nmol/L) PF-C (7) 7.161.2 –87.463.3 122.265.5 350.4651.1 333.968.8*** 244.668.7*** 67.2610.3**
Control VM-C (7) 15.460.8 –82.863.7 110.664.5 169.9618.5 228.665.7 175.965.6
Dofetilide (50 nmol/L) VM-C (7) 16.161.6 –80.963.2 108.662.8 178.4633 261.3611.5* 188.9611
Note: CT, conduction time; RP, resting potential; APA, action potential amplitude; Vmax, maximum rate of depolarization; APD90 and APD50, action potential
durations at 90% and 50% of repolarization. Results are means6 SEM. *p< 0.05, **p< 0.01, ***p< 0.001, Student’s t test for paired data.
Fig. 1. Photographs of an electrotonically coupled ventricular preparation. (A) Pacing microelectrode; (B) microelectrode impaled in a
Purkinje fiber; (C) microelectrode impaled in a ventricular muscle); (D) an uncoupled papillary muscle; (E) an uncoupled Purkinje fiber
inside the tissue bath. [Colour online.]
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(p < 0.01). APA and Vmax did not change. Conduction times (CTs)
slightly increased after dofetilide treatment.
In uncoupled PF preparations (n = 6–6),AQ4 APD90, APD75, and
APD50 were also prolonged after dofetilide treatment (p < 0.001),
but prolongation was more pronounced compared to the change
in coupled preparations (Table 4; Fig. 3D). In uncoupled VM prep-
arations, APD90 to APD25 were all prolonged after dofetilide treat-
ment (p < 0.01). Even though the change in uncoupled VM APD90
is comparable to that of the coupled preparations, the AP of PFs
showed a more pronounced prolongation, unlike with that of
amiodarone treatment, indicated by the greatly increased differ-
ence in average APD90 values.
Discussion
Under control conditions, PF APDs were shorter in coupled
preparations compared to uncoupled preparations, while VM
APDs were longer when coupled with PF, as indicated in the con-
trol values of Tables 1 and 2, when compared to those of Tables 3
and 4. APs recorded from canine transitional cells in the PMJs
have been previously described to have longer APD than VM and
slower maximum rate of depolarization than PF but limited to
the immediate surroundings of the PMJ (Martinez-Palomo et al.
1970), suggesting that the slight prolongation we observed in VM
and abbreviation in PFs when measured in electrotonically
coupled preparations may be attributable to the electrotonic
interaction between VM and PFs. This is not the case in dissected
ventricular and Purkinje preparations (i.e., individual PFs, papil-
lary muscle, or trabecule). Therefore, these latter preparations
are not affected by electrotonic coupling, which also leads to an
exaggerated difference in APD; thus, when calculating dispersion
from individual, uncoupled preparations, dispersion is likely to
be overestimated.
Prolongation of APs in individual VM preparations has been
previously reported after chronic amiodarone treatment, while
PF has been not changed or shortened. Thus, the differences in
APD have been decreased between PF and VM in uncoupled
Fig. 2. The effect of chronic amiodarone (50 mg·kg–1·day–1) in (A and B) coupled and (C and D) uncoupled action potentials. Solid lines
represent Purkinje fiber potentials and dotted lines represent ventricular action potentials; stimulation frequency was 1 Hz. [Colour online.]
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preparations (Papp et al. 1996). In our experiments, amiodarone
was found to prolong APD of PF significantly in electrotonically
coupled, but not in uncoupled, preparations, as seen in Fig. 2,
and in uncoupled preparations resultedAQ5 in no difference between
the APD90 of PFs and VM. However, after chronic amiodarone
treatment in electrotonically coupled preparations, we observed
slight to moderate prolongation of PF repolarization accompa-
nied by a muchmore pronounced prolongation of VM, leading to
a decrease of dispersion of repolarization, reflected as lower
DAPD90 (F4 Fig. 4).
The effect of dofetilide in uncoupled cardiac PF and VM prepa-
rations is well documented (Gwilt et al. 1991; Knilans et al. 1991;
Bányász et al. 2009), but such measurements have not been
reported in ex vivo coupled preparations. Therefore, in this
study, direct comparison between coupled and uncoupled prepa-
rations was possible after dofetilide administration. In coupled
preparations, dofetilide increased DAPD90 by causing a much
greater prolongation in PFs than in VM (Table 2). This difference
in mean APD90 values was further increased in uncoupled prepa-
rations, as seen in Table 4.
The different changes in dispersion may be partially explained
by the different effects of each drug on ion channels: dofetilide is
considered as a selective inhibitor of the delayed rectifier out-
ward potassium current (IKr) (Carmeliet 1992; Kiehn et al. 1994;
Mounsey and DiMarco 2000), while amiodarone also inhibits
inward currents, such as INaL and ICaL (Follmer et al. 1987; Kodama
et al. 1996; Nishimura et al. 1989), and outward currents, such as
IKs, apart from IKr (Balser et al. 1991; Bertran et al. 1998; Kodama
et al. 1996; Sato et al. 1994; Varró et al. 1996). Since INaL is consid-
ered more prominent in PFs than in VM (Baláti et al. 1998; Haufe
et al. 2005), blocking INaL by amiodarone would limit APD length-
ening in PFs more than in VM, resulting in less dispersion of
repolarization.
In this work, we did not study the possible role of calcium sig-
naling in either tissue type. Nevertheless, it is worth mentioning
that in previous studies performed in uncoupled PF and VM
Fig. 3. The effect of dofetilide (50 nmol/L) in (A and B) coupled and (C and D) uncoupled action potentials. Solid lines represent Purkinje
fiber potentials and dotted lines represent ventricular action potentials; stimulation frequency was 1 Hz. [Colour online.]
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preparations, amiodarone abolished EADs and delayed afterde-
polarizations (Varró et al. 2001). On the contrary, several studies
have shown that dofetilide evoked EADs in various cardiac prepa-
rations (Horváth et al. 2015; Nalos et al. 2012; Fedida et al. 2006). AQ6
In some preliminary, additional experiments, we found that in
coupled preparations, dofetilide evoked EADs only when admin-
istered in combination with CsCl and Bay K8644, i.e., a situation
where repolarization reserve had been previously attenuated
and calcium current had been activated. Therefore, understand-
ing calcium signaling in electrotonically coupled preparations
should be an aim of further studies.
The extent of AP prolongation elicited by each drug also varies
between the electronically coupled and uncoupled preparations.
Dofetilide elicited a more pronounced prolongation in uncoupled
PFs compared to changes measured when coupled with VM. This
can bewitnessedwhen comparing Figs. 3B and 3D. PF prolongation
caused by chronic amiodarone treatment was similar in coupled
and uncoupled conditions, but VM prolongation was more pro-
nounced in coupled preparations (Fig. 4). These differences may be
explained by the undisturbed electrotonic coupling between the
PFs and the subendocardial VM, since this interactionmay lead to a
slight decrease in the measured APD of PFs and slight increase in
that of VM, partially evening out the distinct difference in APDs
measured when the conduction system and the myocardium are
dissected. Accordingly, the extent of PF prolongation caused by
dofetilidemay partially bemodulated by the neighboring ventricu-
larmuscle, and the prolongation of VM caused by amiodaronemay
be, in a similar manner, potentiated by the interaction with PFs.
Thus, our data from coupled and uncoupled preparations suggest
that the electrotonic interaction between PFs and subendocardial
myocardium affects not only the baseline electrophysiology of tis-
sues studied using the conventional microelectrode technique but
also themeasured effects elicited by antiarrhythmic agents.
Therefore, amiodarone ex vivo decreased not only transmural
dispersion, previously demonstrated on canine (Sicouri et al.
1997) and human (Drouin et al. 1998) preparations, but also
between PFs and VM. In the clinical setting, the QT/QTc prolonga-
tion increase is associated with an increased risk of VT/VF. How-
ever, drugs that not only increase QT/QTc but also decrease the
dispersion of QT/QTc or JT are accompanied by a lower proar-
rhythmic risk (e.g., amiodarone), while agents that prolong
QT/QTc without a decrease in dispersion (e.g., quinidine) have a
higher risk of arrhythmic events (Cui et al. 1994; Antzelevitch
et al. 1998). It has also been reported that dofetilide increases
Table 3. The electrophysiological effects of 50 mg·kg–1·day–1 amiodarone in uncoupled (“S”) Purkinje fiber (PF) and ventricular muscle (VM)
preparations at a basic cycle length of 1000 ms.
Sample CT (ms) RP (mV) APA (mV) Vmax (V/s) APD90 (ms) APD50 (ms) APD90 difference (ms)
Control PF-S (6) 5.660.6 –87.661.9 128.664.2 535.7642.4 272.3616.2 181.969 65.3
Amiodarone (50 mg·kg–1·day–1) PF-S (7) 4.160.7 –85.763.7 120.866.1 510.3650.9 302.3614.6 161.4621.2 72.2
Control VM-S (10) 6.160.4 –85.860.8 108.263.2 238.9630.9 20764.4 169.964
Amiodarone (50 mg·kg–1·day–1) VM-S (11) 4.660.1## –84.561.6 101.962.6 173.9613.7 230.163.6### 180.363.7
Note: CT, conduction time; RP, resting potential; APA, action potential amplitude; Vmax, maximum rate of depolarization; APD90 and APD50, action potential
durations at 90% and 50% of repolarization. Results are means6 SEM. ##p< 0.01,AQ9 ###p< 0.001, Student’s t test for unpaired data.
Table 4. The electrophysiological effects of 50 nM dofetilide in uncoupled (“S”) Purkinje fiber (PF) and ventricular muscle (VM) preparations at a
basic cycle length of 1000 ms.
Sample CT (ms) RP (mV) APA (mV) Vmax (V/s) APD90 (ms) APD50 (ms) APD90 difference (ms)
Control PF-S (7) 5.560.6 –87.261.8 133.562.6 487.3642.3 280623.5 181.9618.5 81.3
Dofetilide (50 nmol/L) PF-S (7) 6.16 0.8 –88.861.6 134.662.1 446.9640.5 409.9612*** 252.769.6*** 168.1
Control VM-S (6) 6.260.9 –86.262.4 116.763.8 192620.3 198.763.1 163.863
Dofetilide (50 nmol/L) VM-S (6) 6.360.76 –84.662.5 120.663 195.7622.8 241.866.6** 196.666.3**
Note: CT, conduction time; RP, resting potential; APA, action potential amplitude; Vmax, maximum rate of depolarization; APD90 and APD50, action potential
durations at 90% and 50% of repolarization. Results are means6 SEM. **p< 0.01, ***p< 0.001, Student’s t test for unpairedAQ10 data.
Fig. 4. The action potential differences between Purkinje fibers (PF)
and ventricular muscle (VM) in electrotonically coupled and
uncoupled preparations during control conditions after chronic
amiodarone treatment (50 mg·kg–1·day–1) and in the presence of
dofetilide (50 nmol/L). Bars represent means 6 SEM. The white areas
in the PF bars represent the difference in action potential duration
between PF and VM; stimulation frequency was 1 Hz. [Colour online.]
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electrical heterogeneity in the human heart (Stabenau et al.
2020). Dofetilide is associated with a higher risk of causing tor-
sades than amiodarone (Brendorp et al. 2002). Amiodarone has
also been shown to decrease dispersion of monophasic APD90
(Osaka et al. 2011). The decrease in dispersion between the car-
diac conductive system and myocardium may also be a benefi-
cial action of antiarrhythmic agents, similar to the reduction of
transmural dispersion, by decreasing the diversity in refractori-
ness between adjacent cardiac regions, consequently decreasing
the risk of extra beats propagating by unidirectional block.
Conclusion
This study demonstrated that amiodarone, like dofetilide,
lengthened cardiac repolarization but unlike dofetilide, it decreased
dispersion of repolarization in a preparation that preserves elec-
trotonic coupling between PFs and subendocardial VM. Also, car-
diac electrophysiological drug effects can be better established
in preparations with preserved electrotonic coupling than in
uncoupled tissues. The observed marked differences between
the effects of amiodarone and dofetilide on dispersion of repola-
rization in both well-coupled and uncoupled PFs and VM fibers
provide a further explanation why amiodarone has a signifi-
cantly less proarrhythmic risk than dofetilide, in spite of both
drugs exerting a similar degree of QT lengthening in patients.
This effect of amiodarone, unlike that of dofetilide, suggests an
antiarrhythmic effect without a significant proarrhythmic risk.
In addition, this study highlights the importance of studying dis-
persion of repolarization between PFs and VM in well-coupled
preparations, since drug effects can be over- and underestimated
in uncoupled preparations.
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